首页|异痛舒丸治疗卵巢子宫内膜异位囊肿的临床研究

异痛舒丸治疗卵巢子宫内膜异位囊肿的临床研究

扫码查看
目的:探讨异痛舒丸治疗卵巢子宫内膜异位囊肿(OEC)的临床疗效,并评估其安全性.方法:选择符合纳入标准的OEC患者60例,依据随机数字表随机分为对照组和观察组,每组各30例.对照组口服地诺孕素,观察组给予地诺孕素联合异痛舒丸治疗,1个月经周期为1个疗程,连续治疗3个疗程.观察两组患者治疗前后中医证候积分、异位囊肿最大径线、CA125、FSH、LH、E2水平的变化情况,比较临床疗效、中医证候疗效及不良反应发生情况.结果:治疗后,两组患者中医证候疗效比较,观察组总有效率96.67%(29/30),对照组总有效率76.67%(23/30),差异具有统计学意义(P<0.05);两组患者临床疗效比较,观察组临床总有效率93.33%(28/30),对照组临床总有效率73.33%(22/30),差异具有统计学意义(P<0.05).治疗后,两组患者中医证候积分均下降(P<0.05),且观察组较对照组下降更显著(P<0.05);两组患者异位囊肿最大径线均下降(P<0.05),观察组较对照组下降更显著(P<0.05);两组患者血清CA125、FSH、LH及E2水平均下降(P<0.05),观察组较对照组下降更显著(P<0.05);治疗过程中两组患者未出现不良反应.结论:异痛舒丸治疗OEC疗效显著,可有效改善OEC患者临床症状与体征,降低中医证候积分,调节血清CA125、FSH、LH及E2水平,缩小异位囊肿,不良反应发生率低.
Clinical Study on Yitong Shu Pill in the Treatment of Ovarian Endometriosis Cysts
Objective:To explore the clinical efficacy and safety of Yitong Shu Pill(YSP)in the treatment of ovarian endometrial cysts(OEC).Methods:Sixty OEC patients who met the inclusion criteria were selected and randomly divided into a control group and an observation group based on a random number table,with 30 cases in each group.The control group received oral administration of denorgestrel,while the observation group received the same in addition to YSP.One menstrual cycle was considered as a course of treatment,and the treatment lasted for three consecutive courses.Changes in traditional Chinese medicine syndrome scores,maximum diameter of ectopic cysts,CA125,FSH,LH,and E2 levels before and after treatment in the two groups of patients were observed,and the clinical efficacy,traditional Chinese medicine syndrome efficacy,and adverse reactions in the two groups were compared.Results:After treatment,the total effective rate of traditional Chinese medicine syndromes in the observation group was 96.67%(29/30),while that of the control group was 76.67%(23/30),with a statistically significant difference(P<0.05).Total clinical effective rate was 93.33%(28/30)in the observation group and 73.33%(22/30)in the control group,and the difference was statistically significant(P<0.05).The traditional Chinese medicine syndrome scores of both groups decreased(P<0.05),and they decreased more in observation group than in the control group(P<0.05).The maximum diameter of ectopic cysts in both groups of patients decreased(P<0.05),and the diameter decreased more in the observation group than in the control group(P<0.05).The serum CA125 levels in both groups of patients decreased(P<0.05),and the observation group showed more significant compared to the control group(P<0.05).The serum levels of CA125,FSH,LH,and E2 in both groups of patients decreased,and the observation group was obvious compared with the control group(P<0.05).During the treatment process,there were no adverse reactions observed in both groups of patients.Conclusion:Yitong Shu Pill has a significant therapeutic effect on OEC,which can effectively improve clinical symptoms and signs of OEC patients,reduce traditional Chinese medicine syndrome scores,regulate serum levels of CA125,FSH,LH,and E2,reduce the size of ectopic cysts,and have a low incidence of adverse reactions.

Yitong Shu PillOvarian endometriotic cystCA125FSHLHE2

韩明轩、郭滢、孟小钰、李佳、胡佳裕、唐茂艳、韩凤娟

展开 >

黑龙江中医药大学,黑龙江 哈尔滨 150040

黑龙江中医药大学附属第一医院,黑龙江哈尔滨 150040

中国中医科学院西苑医院,北京 100091

异痛舒丸 卵巢子宫内膜异位囊肿 CA125 FSH LH E2

国家中医药管理局中医科技与创新能力提升项目

国中医药科技中药便函[2023]24号

2024

中医药信息
中华中医药学会,黑龙江中医药大学

中医药信息

影响因子:1.219
ISSN:1002-2406
年,卷(期):2024.41(2)
  • 16